Wednesday, March 9, 2011
FDA approves Human Genome's Benlysta for lupus
SAN FRANCISCO (MarketWatch) -- The US Food and Drug Administration on Wednesday approved Benlysta, a treatment for lupus from Human Genome Sciences .
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment